Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Vivos Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 16 | 19 | +3 |
| Shares | 136.4K | 186.9K | +50.5K (+37.0%) |
| Value | $646.8K | $433.8K | −$212.9K (−32.9%) |
New holders (5)
Institutions that held Vivos Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Strategic Wealth Designers | 128,789 | $303.9K | 0.04% |
| Geode Capital Management, LLC | 20,691 | $45.9K | 0.00% |
| Triad Wealth Partners, LLC | 2,818 | $6.26K | 0.00% |
| Advisor Group Holdings, Inc. | 898 | $1.99K | 0.00% |
| TD Waterhouse Canada Inc. | 12 | $28 | 0.00% |
Sold out (2)
Institutions that held Vivos Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Armistice Capital, LLC | 103,582 | $500.3K |
| Wells Fargo & Company | 7 | $34 |